BioSpace News Archive

Business

Akebia Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results

Akebia Therapeutics, Inc. announced financial results for the fourth quarter and full year ended December 31, 2017.

March 12, 2018
·
6 min read
Business

Illumina Names Dr. Phil Febbo Chief Medical Officer

Illumina, Inc. announced the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2018.

March 12, 2018
·
2 min read
Business

Enzo Biochem Reports Second Quarter and First Half Results

Enzo Biochem (NYSE:ENZ) today announced results for the fiscal quarter and six months ended January 31, 2018.

March 12, 2018
·
8 min read
Business

Advaxis Reports Fiscal 2018 First Quarter Financial Results and Announces Clinical Hold in Axalimogene Filolisbac Phase 1/2 Combination Study with AstraZeneca’s IMFINZI® (Durvalumab)

Advaxis, Inc. announces financial results for the three months ended January 31, 2018 and provides a business update.

March 12, 2018
·
6 min read
Business

Cellectis Reports 4th Quarter and Full Year 2017 Financial Results

Cellectis announced its results for the three-month period ended December 31, 2017 and for the year ended December 31, 2017.

March 12, 2018
·
15 min read
Business

Brookdale to Present at the Barclays Global Healthcare Conference

Brookdale Senior Living Inc. announced that management will participate in the Barclays Global Healthcare Conference in Miami Beach, FL, on Thursday, March 15, 2018.

March 12, 2018
·
1 min read
Policy

Calyxt Filed Complaint in Delaware Chancery Court Against Bayer CropScience, LP

Calyxt, Inc. announced that it has filed a complaint in Delaware Chancery Court against Bayer CropScience LP.

March 12, 2018
·
1 min read
Drug Development

Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of GI Cancer Trial

The Guardant360® assay will be used to launch a new arm of a nationwide trial run by SCRUM-Japan GI-SCREEN, organized by the National Cancer Center Hospital East (NCCE), Kashiwa, Japan.

March 12, 2018
·
1 min read
Drug Development

Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of Lung Cancer Trial

The Guardant360® assay will be used as the sole liquid biopsy in LC-SCRUM-Japan, a nationwide genomic screening network run by the National Cancer Center Hospital East (NCCE) Kashiwa, Japan to match metastatic lung cancer patients with approved drugs and experimental therapies in clinical trials.

March 12, 2018
·
1 min read
BioForest

Federal Panel Calls for Urgent Collaborative Action to Align Cancer Drug Prices with Value

Urgent action must be taken to address the dramatic rise of cancer drug prices and to better align prices with value, according to a report released by the President’s Cancer Panel.

March 12, 2018
·
4 min read